HK1025220A1 - Novel saponin compositions and uses thereof - Google Patents

Novel saponin compositions and uses thereof

Info

Publication number
HK1025220A1
HK1025220A1 HK00102685A HK00102685A HK1025220A1 HK 1025220 A1 HK1025220 A1 HK 1025220A1 HK 00102685 A HK00102685 A HK 00102685A HK 00102685 A HK00102685 A HK 00102685A HK 1025220 A1 HK1025220 A1 HK 1025220A1
Authority
HK
Hong Kong
Prior art keywords
novel combinations
vaccines
saponin compositions
novel saponin
novel
Prior art date
Application number
HK00102685A
Other languages
English (en)
Inventor
Kensil Charlotte
Original Assignee
Antigenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antigenics Inc filed Critical Antigenics Inc
Publication of HK1025220A1 publication Critical patent/HK1025220A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK00102685A 1996-12-02 2000-05-03 Novel saponin compositions and uses thereof HK1025220A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/019252 WO1998024319A1 (en) 1996-12-02 1996-12-02 Novel saponin compositions and uses thereof

Publications (1)

Publication Number Publication Date
HK1025220A1 true HK1025220A1 (en) 2000-11-10

Family

ID=22256230

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00102685A HK1025220A1 (en) 1996-12-02 2000-05-03 Novel saponin compositions and uses thereof

Country Status (10)

Country Link
EP (1) EP0952771B1 (de)
JP (1) JP4138884B2 (de)
AT (1) ATE385809T1 (de)
AU (1) AU730230B2 (de)
CA (1) CA2273922C (de)
DE (1) DE69637435T2 (de)
DK (1) DK0952771T3 (de)
ES (1) ES2297841T3 (de)
HK (1) HK1025220A1 (de)
WO (1) WO1998024319A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2993582C (en) 2008-04-08 2020-12-15 Sloan-Kettering Institute For Cancer Research Triterpene saponins, methods of synthesis, and uses thereof
GB201213364D0 (en) * 2012-07-27 2012-09-12 Glaxosmithkline Biolog Sa Purification process
DE102017220416A1 (de) 2016-11-18 2018-05-24 Sms Group Gmbh Verfahren und Vorrichtung zur Herstellung eines kontinuierlichen bandförmigen Verbundmaterials
US11591364B2 (en) 2017-12-01 2023-02-28 Glaxosmithkline Biologicals Sa Saponin purification
EP3717005A1 (de) * 2017-12-01 2020-10-07 GlaxoSmithKline Biologicals S.A. Saponinextraktion
CN114080393A (zh) * 2019-06-05 2022-02-22 葛兰素史克生物有限公司 皂苷纯化

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US5273965A (en) * 1992-07-02 1993-12-28 Cambridge Biotech Corporation Methods for enhancing drug delivery with modified saponins
US5650398A (en) * 1992-07-02 1997-07-22 Cambridge Biotech Corporation Drug delivery enhancement via modified saponins
AUPM873294A0 (en) * 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms

Also Published As

Publication number Publication date
CA2273922C (en) 2008-08-05
AU1277897A (en) 1998-06-29
EP0952771B1 (de) 2008-02-13
ES2297841T3 (es) 2008-05-01
WO1998024319A1 (en) 1998-06-11
EP0952771A1 (de) 1999-11-03
AU730230B2 (en) 2001-03-01
EP0952771A4 (de) 2004-11-03
DE69637435T2 (de) 2009-02-19
JP4138884B2 (ja) 2008-08-27
CA2273922A1 (en) 1998-06-11
DE69637435D1 (de) 2008-03-27
JP2001505573A (ja) 2001-04-24
ATE385809T1 (de) 2008-03-15
DK0952771T3 (da) 2008-05-19

Similar Documents

Publication Publication Date Title
DK1104306T3 (da) Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf
HUP9801560A1 (hu) Szaponint és szterint tartalmazó vakcinák
NZ323973A (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
NZ331651A (en) BSW17 peptide immunogens for vaccination against and treatment of allergy
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
HUP0402067A2 (hu) Oltóanyagok
EP1955709A3 (de) Adjuvanzverbindungen zur Verbesserung von Immunreaktionen auf Polynukleotid-basierten Impfstoffen
PL351893A1 (en) Vaccines
HUP0101619A2 (hu) Adjuvánskészítmények
NZ319377A (en) polypeptides comprising a portion of a soluble M tuberculosis antigen
ATE496630T1 (de) Immunologische zusammensetzung und impfstoffe, die einen auf n-formyl-methionyl peptide bestehenden adjuvans enthalten
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
AU2001295673A1 (en) Vaccine composition
GB2255093A (en) Hiv-1 core protein fragments
IL107262A0 (en) Oral vaccines comprising multiple emulsions and methods of preparation
MY125000A (en) Novel compositions
EP1385541A4 (de) Immunostimulierende zusammnensetzungen die aminoalkyl glucosaminidephosphat und qs-21 enthalten
WO2001039803A3 (en) Interleukin-1 muteins useful as vaccine adjuvants
GEP20053446B (en) Adjuvant Combination Formulations
HK1025220A1 (en) Novel saponin compositions and uses thereof
EP1131338A4 (de) Methode für die herstellung von gereinigtem invasinprotein und seine anwendung
MY127452A (en) Vaccines.
UA42741C2 (uk) Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти)
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
WO2002036160A3 (es) Método de obtención de estructuras antigénicas que potencian la reactividad cruzada específica

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131202